Literature DB >> 9008780

Delayed-onset hemidystonia and chorea following contralateral infarction of the posterolateral thalamus. A case report.

M Gille1, P Van den Bergh, S Ghariani, L Guettat, J Delbecq, A Depre.   

Abstract

A 68 year-old man developed progressive hemidystonia and chorea 8 months after a contralateral thalamic stroke. The neurological examination also showed a right pyramidal syndrome without hemiparesis, a right horizontal sectoranopia, and a right hemihypesthesia for all sensory modalities. The MRI revealed infarctions in the left medial temporo-occipital lobes and left posterolateral thalamus, corresponding to the vascular territories of both the thalamo-geniculate and posterolateral choroidal arterial pedicles. The thalamic lesion involved the pulvinar, the lateral geniculate body, and the ventro-postero-lateral, dorso-lateral, posterolateral, and dorso-medial nuclei, but apparently did not extent to the ventrolateral thalamic nucleus, and the subthalamic and midbrain regions. Thalamic and striatopallidal dystonia have not a common pathophysiological mechanism. The involvement of the pulvinar nucleus and of the strategic crossing of proprioceptive, cerebellar, pyramidal, and subthalamic pathways may play a role in the genesis of the posterolateral thalamic dystonia.

Entities:  

Mesh:

Year:  1996        PMID: 9008780

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  2 in total

Review 1.  The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature.

Authors:  C Chuang; S Fahn; S J Frucht
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

2.  Pure hemi-chorea resulting from an acute phase of contralateral thalamic lacunar infarction: a case report.

Authors:  Teruyuki Takahashi; Hideaki Kanamori; Rihiro Shigehara; Sachiko Nonaka Takahashi; Masato Tamura; Toshiaki Takasu; Marohito Murakami
Journal:  Case Rep Neurol       Date:  2012-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.